Gene manipulation with stereotaxic viral infection for psychiatric research: Spatiotemporal components for schizophrenia

Progress in Brain Research

Volumn 179, Issue C, 2009, Pages 17-27

  Seshadri, Anupamaa J ^a   Hayashi Takagi, Akiko ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

A polygenic disease; Schizophrenia (SZ); Spatiotemporal gene manipulation; Stereotaxic viral injection; Susceptible neural circuits for SZ

Indexed keywords

ANIMAL; BRAIN; DISEASE MODEL; GENE TRANSFER; GENE VECTOR; GENETIC ENGINEERING; GENETIC PREDISPOSITION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METHODOLOGY; PATHOPHYSIOLOGY; REVIEW; SCHIZOPHRENIA; STEREOTACTIC PROCEDURE; VIRUS;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; GENE TRANSFER TECHNIQUES; GENETIC ENGINEERING; GENETIC PREDISPOSITION TO DISEASE; GENETIC VECTORS; HUMANS; SCHIZOPHRENIA; STEREOTAXIC TECHNIQUES; VIRUSES;

EID: 77953471197     PISSN: 00796123     EISSN: 18757855     Source Type: Book Series    
DOI: 10.1016/S0079-6123(09)17903-7     Document Type: Article

References (79)

1. Andreasen, N. C., Rezai, K., Alliger, R., Swayze, V. W., 2nd, Flaum, M., Kirchner, P., et al. (1992). Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Archives in General Psychiatry, 49, 943-958.
2. Andreasson, S., Allebeck, P., Engstrom, A., & Rydberg, U. (1987). Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet, 2, 1483-1486.
3. Arnold, S. E., Talbot, K., & Hahn, C. G. (2005). Neurodevelopment, neuroplasticity, and new genes for schizophrenia. Progress in Brain Research, 147, 319-345.
4. Arnsten, A. F. (2009). Stress signalling pathways that impair prefrontal cortex structure and function. Nature Reviews Neuroscience, 10, 410-422.
5. Benes, F. M. (2000). Emerging principles of altered neural circuitry in schizophrenia. Brain Research Reviews, 31, 251-269.
6. Brown, A. S., Begg, M. D., Gravenstein, S., Schaefer, C. A., Wyatt, R. J., Bresnahan, M., et al. (2004). Serologic evidence of prenatal influenza in the etiology of schizophrenia. Archives in General Psychiatry, 61, 774-780.
7. Buka, S. L., Cannon, T. D., Torrey, E. F., & Yolken, R. H. (2008). Maternal exposure to herpes simplex virus and risk of psychosis among adult offspring. Biological Psychiatry, 63, 809-815.
8. Calkins, M. E., Dobie, D. J., Cadenhead, K. S., Olincy, A., Freedman, R., Green, M. F., et al. (2007). The consortium on the genetics of endophenotypes in schizophrenia: Model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophrenia Bulletin, 33, 33-48.
9. Cannon, M., Jones, P. B., & Murray, R. M. (2002). Obstetric complications and schizophrenia: Historical and meta-analytic review. American Journal of Psychiatry, 159, 1080-1092.
10. Cannon, T. D., van Erp, T. G., Bearden, C. E., Loewy, R., Thompson, P., Toga, A. W., et al. (2003). Early and late neurodevelopmental influences in the prodrome to schizophrenia: Contributions of genes, environment, and their interactions. Schizophrenia Bulletin, 29, 653-669.
11. Carter, C. J. (2008). Schizophrenia susceptibility genes directly implicated in the life cycles of pathogens: Cytomegalovirus, influenza, herpes simplex, rubella, and toxoplasma gondii. Schizophrenia Bulletin
12. Castner, S. A., Goldman-Rakic, P. S., & Williams, G. V. (2004). Animal models of working memory: Insights for targeting cognitive dysfunction in schizophrenia. Psychopharmacology (Berl), 174, 111-125.
13. Cetin, A., Komai, S., Eliava, M., Seeburg, P. H., & Osten, P. (2006). Stereotaxic gene delivery in the rodent brain. Nature Protocols, 1, 3166-3173.
14. Cronin, J., Zhang, X. Y., & Reiser, J. (2005). Altering the tropism of lentiviral vectors through pseudotyping. Current Gene Therapy, 5, 387-398.
15. Davidson, B. L., & Breakefield, X. O. (2003). Viral vectors for gene delivery to the nervous system. Nature Reviews Neuroscience, 4, 353-364.
16. Davidson, L. L., & Heinrichs, R. W. (2003). Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: A meta-analysis. Psychiatry Research, 122, 69-87.
17. Davis, K. L., Kahn, R. S., Ko, G., & Davidson, M. (1991). Dopamine in schizophrenia: A review and reconceptualization. American Journal of Psychiatry, 148, 1474-1486.
18. Ehrengruber, M. U., & Lundstrom, K. (2002). Semliki Forest virus and Sindbis virus vectors. Current Protocols in Human Genetics, Chapter 12, Unit 12. 12.
19. Ehrengruber, M. U., & Lundstrom, K. (2007). Alphaviruses: Semliki Forest virus and Sindbis virus vectors for gene transfer into neurons. Current Protocols in Neuroscience, Chapter 4, Unit 4. 22.
20. Epstein, A. L., Marconi, P., Argnani, R., & Manservigi, R. (2005). HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy. Current Gene Therapy, 5, 445-458.
21. Friston, K. J. (1998). The disconnection hypothesis. Schizophrenia Research, 30, 115-125.
22. Garey, L. J., Ong, W. Y., Patel, T. S., Kanani, M., Davis, A., Mortimer, A. M., et al. (1998). Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. Journal of Neurology, Neurosurgery and Psychiatry, 65, 446-453.
23. Garrity, A. G., Pearlson, G. D., McKiernan, K., Lloyd, D., Kiehl, K. A., & Calhoun, V. D. (2007). Aberrant "default mode" functional connectivity in schizophrenia. American Journal of Psychiatry, 164, 450-457.
24. Geyer, M. A. (1998). Behavioral studies of hallucinogenic drugs in animals: Implications for schizophrenia research. Pharmacopsychiatry, 31(Suppl 2), 73-79.
25. Glantz, L. A., & Lewis, D. A. (2000). Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Archives in General Psychiatry, 57, 65-73.
26. Goff, D. C., & Coyle, J. T. (2001). The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. American Journal of Psychiatry, 158, 1367-1377.
27. Gottesman, I. (1991). Schizophrenia genesis: The origins of madnessNew York: W.H. Freeman.
28. Haber, S., & McFarland, N. R. (2001). The place of the thalamus in frontal cortical-basal ganglia circuits. Neuroscientist, 7, 315-324.
29. Halim, N. D., Lipska, B. K., Hyde, T. M., Deep-Soboslay, A., Saylor, E. M., Herman, M. M., et al. (2008). Increased lactate levels and reduced pH in postmortem brains of schizophrenics: Medication confounds. Journal of Neuroscience Methods, 169, 208-213.
30. Harrison, P. J. (1999). The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain, 122 (Pt 4), 593-624.
31. Harrison, P. J., & Weinberger, D. R. (2005). Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Molecular Psychiatry, 10, 40-68. Image 45.
32. Hashimoto, K., Sawa, A., & Iyo, M. (2007). Increased levels of glutamate in brains from patients with mood disorders. Biological Psychiatry, 62, 1310-1316.
33. Jaaro-Peled, H., Hayashi-Takagi, A., Seshadri, S., Kamiya, A., Brandon, N.J., & Sawa, A. (2009). Neurodevelopmental mechanisms of schizophrenia: Understanding disturbed postnatal brain maturation through Neuregulin-1 and DISC1. Trends in Neuroscience, 32(9), 485-495. [Epub 2009 Aug 26.]
34. Javitt, D. C., & Zukin, S. R. (1991). Recent advances in the phencyclidine model of schizophrenia. American Journal of Psychiatry, 148, 1301-1308.
35. Jeromin, A., Yuan, L. L., Frick, A., Pfaffinger, P., & Johnston, D. (2003). A modified Sindbis vector for prolonged gene expression in neurons. Journal of Neurophysiology, 90, 2741-2745.
36. Jin, D., Liu, H. X., Hirai, H., Torashima, T., Nagai, T., Lopatina, O., et al. (2007). CD38 is critical for social behaviour by regulating oxytocin secretion. Nature, 446, 41-45.
37. Jones, E. G. (2001). The thalamic matrix and thalamocortical synchrony. Trends in Neuroscience, 24, 595-601.
38. Kellendonk, C., Simpson, E. H., & Kandel, E. R. (2009). Modeling cognitive endophenotypes of schizophrenia in mice. Trends in Neuroscience, 32, 347-358.
39. Kim, J., Dittgen, T., Nimmerjahn, A., Waters, J., Pawlak, V., Helmchen, F., et al. (2004). Sindbis vector SINrep (nsP2S726): A tool for rapid heterologous expression with attenuated cytotoxicity in neurons. Journal of Neuroscience Methods, 133, 81-90.
40. Kolluri, N., Sun, Z., Sampson, A. R., & Lewis, D. A. (2005). Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. American Journal of Psychiatry, 162, 1200-1202.
41. Lewis, D. A., & Levitt, P. (2002). Schizophrenia as a disorder of neurodevelopment. Annual Review of Neuroscience, 25, 409-432.
42. Lewis, D. A., & Lieberman, J. A. (2000). Catching up on schizophrenia: Natural history and neurobiology. Neuron, 28, 325-334.
43. Lewis, G., David, A., Andreasson, S., & Allebeck, P. (1992). Schizophrenia and city life. Lancet, 340, 137-140.
44. Li, J. Z., Vawter, M. P., Walsh, D. M., Tomita, H., Evans, S. J., Choudary, P. V., et al. (2004). Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Human Molecular Genetics, 13, 609-616.
45. Lingor, P., Scholl, U., Bahr, M., & Kugler, S. (2005). Functional applications of novel Semliki Forest virus vectors are limited by vector toxicity in cultures of primary neurons in vitro and in the substantia nigra in vivo. Experimental Brain Research, 161, 335-342.
46. Lipska, B. K., Jaskiw, G. E., & Weinberger, D. R. (1993). Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: A potential animal model of schizophrenia. Neuropsychopharmacology, 9, 67-75.
47. Mao, Y., Ge, X., Frank, C. L., Madison, J. M., Koehler, A. N., Doud, M. K., et al. (2009). Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell, 136, 1017-1031.
48. Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B. P., Guilloux, J. P., et al. (2005). Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature, 436, 103-107.
49. McClellan, J. M., Susser, E., & King, M. C. (2007). Schizophrenia: A common disease caused by multiple rare alleles. British Journal of Psychiatry, 190, 194-199.
50. McGlashan, T. H., & Hoffman, R. E. (2000). Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Archives in General Psychiatry, 57, 637-648.
51. McGuire, P., Howes, O. D., Stone, J., & Fusar-Poli, P. (2008). Functional neuroimaging in schizophrenia: Diagnosis and drug discovery. Trends in Pharmacological Sciences, 29, 91-98.
52. Mednick, S. A., Machon, R. A., Huttunen, M. O., & Bonett, D. (1988). Adult schizophrenia following prenatal exposure to an influenza epidemic. Archives in General Psychiatry, 45, 189-192.
53. Minzenberg, M. J., Laird, A. R., Thelen, S., Carter, C. S., & Glahn, D. C. (2009). Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Archives in General Psychiatry, 66, 811-822.
54. Moghaddam, B. (2003). Bringing order to the glutamate chaos in schizophrenia. Neuron, 40, 881-884.
55. Mortensen, P. B., Pedersen, C. B., Westergaard, T., Wohlfahrt, J., Ewald, H., Mors, O., et al. (1999). Effects of family history and place and season of birth on the risk of schizophrenia. New England Journal of Medicine, 340, 603-608.
56. Owen, M. J., Craddock, N., & O'Donovan, M. C. (2005). Schizophrenia: Genes at last? Trends in Genetics, 21, 518-525.
57. Pantelis, C., Velakoulis, D., McGorry, P. D., Wood, S. J., Suckling, J., Phillips, L. J., et al. (2003). Neuroanatomical abnormalities before and after onset of psychosis: A crosssectional and longitudinal MRI comparison. Lancet, 361, 281-288.
58. Pedersen, C. B., & Mortensen, P. B. (2001). Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Archives in General Psychiatry, 58, 1039-1046.
59. Pierce, R. C., & Kalivas, P. W. (1997). A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Research Reviews, 25, 192-216.
60. Rapoport, J. L., Addington, A. M., Frangou, S., & Psych, M. R. (2005). The neurodevelopmental model of schizophrenia: Update 2005. Molecular Psychiatry, 10, 434-449.
61. Sawa, A., & Snyder, S. H. (2002). Schizophrenia: Diverse approaches to a complex disease. Science, 296, 692-695.
62. Stefansson, H., Ophoff, R. A., Steinberg, S., Andreassen, O.A., Cichon, S., Rujescu, D., et al. (2009). Common variants conferring risk of schizophrenia. Nature, 460, 744-747.
63. Steriade, M. (2006). Grouping of brain rhythms in corticothalamic systems. Neuroscience, 137, 1087-1106.
64. Sun, D., Stuart, G. W., Jenkinson, M., Wood, S. J., McGorry, P.D., Velakoulis, D., et al. (2008). Brain surface contraction mapped in first-episode schizophrenia: A longitudinal magnetic resonance imaging study. Molecular Psychiatry
65. Swerdlow, N. R., Geyer, M. A., & Braff, D. L. (2001). Neural circuit regulation of prepulse inhibition of startle in the rat: Current knowledge and future challenges. Psychopharmacology (Berl), 156, 194-215.
66. Tabata, H., & Nakajima, K. (2001). Efficient in utero gene transfer system to the developing mouse brain using electroporation: Visualization of neuronal migration in the developing cortex. Neuroscience, 103, 865-872.
67. Thompson, P. M., Vidal, C., Giedd, J. N., Gochman, P., Blumenthal, J., Nicolson, R., et al. (2001). Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proceedings of the National Academy of Sciences United States of America, 98, 11650-11655.
68. Torrey, E. F., Miller, J., Rawlings, R., & Yolken, R. H. (1997). Seasonality of births in schizophrenia and bipolar disorder: A review of the literature. Schizophrenia Research, 28, 1-38.
69. Tseng, K. Y., Chambers, R. A., & Lipska, B. K. (2008). The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia. Behavioral Brain Research
70. Tsien, J. Z., Chen, D. F., Gerber, D., Tom, C., Mercer, E. H., Anderson, D. J., et al. (1996). Subregion- and cell typerestricted gene knockout in mouse brain. Cell, 87, 1317-1326.
71. Vidal, C. N., Rapoport, J. L., Hayashi, K. M., Geaga, J. A., Sui, Y., McLemore, L. E., et al. (2006). Dynamically spreading frontal and cingulate deficits mapped in adolescents with schizophrenia. Archives in General Psychiatry, 63, 25-34.
72. Weber, K., Rockstroh, B., Borgelt, J., Awiszus, B., Popov, T., Hoffmann, K., et al. (2008). Stress load during childhood affects psychopathology in psychiatric patients. BMC Psychiatry, 8, 63.
73. Weinberger, D. R. (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Archives in General Psychiatry, 44, 660-669.
74. Welch, J. M., Lu, J., Rodriguiz, R. M., Trotta, N. C., Peca, J., Ding, J. D., et al. (2007). Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature, 448, 894-900.
75. Winterer, G., & Weinberger, D. R. (2004). Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends in Neuroscience, 27, 683-690.
76. Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W., David, A. S., Murray, R. M., & Bullmore, E. T. (2000). Meta-analysis of regional brain volumes in schizophrenia. American Journal of Psychiatry, 157, 16-25.
77. Yang, L., Bailey, L., Baltimore, D., & Wang, P. (2006). Targeting lentiviral vectors to specific cell types in vivo. Proceedings of the National Academy of Sciences United States of America, 103, 11479-11484.
78. Yang, Y., Li, Q., Ertl, H. C., & Wilson, J. M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. Journal of Virology, 69, 2004-2015.
79. Yolken,R. H.,&Torrey, E. F. (1995).Viruses, schizophrenia, and bipolar disorder. Clinical Microbiology Reviews, 8, 131-145.